AR023282A1 - Derivados de higromicina - Google Patents
Derivados de higromicinaInfo
- Publication number
- AR023282A1 AR023282A1 ARP000105698A ARP000105698A AR023282A1 AR 023282 A1 AR023282 A1 AR 023282A1 AR P000105698 A ARP000105698 A AR P000105698A AR P000105698 A ARP000105698 A AR P000105698A AR 023282 A1 AR023282 A1 AR 023282A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- above compounds
- hygromycin
- derivatives
- hygromycin derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a compuestos de la formula (1) y a sales, promedicamentos y solvatos farmacéuticamente aceptables de éstos, en los que X, Y, V, W1,,W2, Z1 y Z2 son como se han definido. Se divulgan también composiciones farmacéuticas que contienen los compuestos anteriores y procedimientos de tratamientode infecciones bacterianas y protozoarias en mamíferos por administracion de los compuestos anteriores.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16258199P | 1999-10-29 | 1999-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR023282A1 true AR023282A1 (es) | 2002-09-04 |
Family
ID=22586256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000105698A AR023282A1 (es) | 1999-10-29 | 2000-10-27 | Derivados de higromicina |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6562792B1 (es) |
| EP (1) | EP1224197A1 (es) |
| JP (1) | JP2003512473A (es) |
| KR (1) | KR20020063885A (es) |
| CN (1) | CN1382150A (es) |
| AP (1) | AP2002002494A0 (es) |
| AR (1) | AR023282A1 (es) |
| AU (1) | AU7549400A (es) |
| BG (1) | BG106727A (es) |
| BR (1) | BR0015153A (es) |
| CA (1) | CA2389191A1 (es) |
| CO (1) | CO5261498A1 (es) |
| CZ (1) | CZ20021355A3 (es) |
| EA (1) | EA200200292A1 (es) |
| EE (1) | EE200200228A (es) |
| GT (1) | GT200000185A (es) |
| HK (1) | HK1049672A1 (es) |
| HU (1) | HUP0203525A3 (es) |
| IL (1) | IL148577A0 (es) |
| IS (1) | IS6311A (es) |
| MA (1) | MA26838A1 (es) |
| MX (1) | MXPA02004360A (es) |
| NO (1) | NO20021850D0 (es) |
| OA (1) | OA12081A (es) |
| PA (1) | PA8505801A1 (es) |
| PE (1) | PE20010763A1 (es) |
| PL (1) | PL357083A1 (es) |
| SK (1) | SK5472002A3 (es) |
| SV (1) | SV2002000211A (es) |
| TN (1) | TNSN00211A1 (es) |
| TR (1) | TR200201145T2 (es) |
| WO (1) | WO2001030795A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE200200671A (et) * | 2000-06-02 | 2004-08-16 | Pfizer Products Inc. | Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks |
| US6653481B2 (en) * | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
| US7923439B2 (en) * | 2008-10-15 | 2011-04-12 | Tyco Healthcare Group Lp | Hydroxamate compositions |
| US20210275559A1 (en) * | 2018-08-20 | 2021-09-09 | Kim Lewis | Hygromycin a compounds and methods of treating spirochete diseases |
| US11834441B2 (en) | 2019-12-06 | 2023-12-05 | Vertex Pharmaceuticals Incorporated | Substituted tetrahydrofurans as modulators of sodium channels |
| EP4347031A1 (en) | 2021-06-04 | 2024-04-10 | Vertex Pharmaceuticals Incorporated | N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0104949A3 (en) * | 1998-12-02 | 2003-12-29 | Pfizer Prod Inc | Hygromycin a derivatives as antibacterial agents process for preparing them and pharmaceutical compositions comprising them |
-
2000
- 2000-10-09 PL PL00357083A patent/PL357083A1/xx not_active Application Discontinuation
- 2000-10-09 JP JP2001533146A patent/JP2003512473A/ja active Pending
- 2000-10-09 IL IL14857700A patent/IL148577A0/xx unknown
- 2000-10-09 KR KR1020027005533A patent/KR20020063885A/ko not_active Application Discontinuation
- 2000-10-09 WO PCT/IB2000/001461 patent/WO2001030795A1/en not_active Application Discontinuation
- 2000-10-09 CN CN00814843A patent/CN1382150A/zh active Pending
- 2000-10-09 EE EEP200200228A patent/EE200200228A/xx unknown
- 2000-10-09 AU AU75494/00A patent/AU7549400A/en not_active Abandoned
- 2000-10-09 TR TR2002/01145T patent/TR200201145T2/xx unknown
- 2000-10-09 EP EP00964572A patent/EP1224197A1/en not_active Withdrawn
- 2000-10-09 MX MXPA02004360A patent/MXPA02004360A/es active IP Right Grant
- 2000-10-09 SK SK547-2002A patent/SK5472002A3/sk not_active Application Discontinuation
- 2000-10-09 EA EA200200292A patent/EA200200292A1/ru unknown
- 2000-10-09 AP APAP/P/2002/002494A patent/AP2002002494A0/en unknown
- 2000-10-09 OA OA1200200129A patent/OA12081A/en unknown
- 2000-10-09 CA CA002389191A patent/CA2389191A1/en not_active Abandoned
- 2000-10-09 HU HU0203525A patent/HUP0203525A3/hu unknown
- 2000-10-09 BR BR0015153-0A patent/BR0015153A/pt not_active IP Right Cessation
- 2000-10-09 CZ CZ20021355A patent/CZ20021355A3/cs unknown
- 2000-10-20 US US09/693,118 patent/US6562792B1/en not_active Expired - Fee Related
- 2000-10-25 CO CO00081374A patent/CO5261498A1/es not_active Application Discontinuation
- 2000-10-25 GT GT200000185A patent/GT200000185A/es unknown
- 2000-10-26 PE PE2000001146A patent/PE20010763A1/es not_active Application Discontinuation
- 2000-10-26 PA PA20008505801A patent/PA8505801A1/es unknown
- 2000-10-27 SV SV2000000211A patent/SV2002000211A/es unknown
- 2000-10-27 AR ARP000105698A patent/AR023282A1/es not_active Application Discontinuation
- 2000-10-27 TN TNTNSN00211A patent/TNSN00211A1/fr unknown
-
2002
- 2002-03-19 IS IS6311A patent/IS6311A/is unknown
- 2002-04-19 NO NO20021850A patent/NO20021850D0/no not_active Application Discontinuation
- 2002-04-22 MA MA26613A patent/MA26838A1/fr unknown
- 2002-05-20 BG BG106727A patent/BG106727A/bg unknown
-
2003
- 2003-03-14 HK HK03101860.2A patent/HK1049672A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EE200200228A (et) | 2003-06-16 |
| KR20020063885A (ko) | 2002-08-05 |
| TNSN00211A1 (fr) | 2005-11-10 |
| AP2002002494A0 (en) | 2002-06-30 |
| BR0015153A (pt) | 2002-07-16 |
| HUP0203525A3 (en) | 2003-08-28 |
| PA8505801A1 (es) | 2002-08-26 |
| TR200201145T2 (tr) | 2002-09-23 |
| WO2001030795A1 (en) | 2001-05-03 |
| BG106727A (bg) | 2003-01-31 |
| MA26838A1 (fr) | 2004-12-20 |
| SV2002000211A (es) | 2002-07-16 |
| PL357083A1 (en) | 2004-07-12 |
| CN1382150A (zh) | 2002-11-27 |
| MXPA02004360A (es) | 2002-11-07 |
| CA2389191A1 (en) | 2001-05-03 |
| EA200200292A1 (ru) | 2002-10-31 |
| NO20021850L (no) | 2002-04-19 |
| IS6311A (is) | 2002-03-19 |
| CO5261498A1 (es) | 2003-03-31 |
| IL148577A0 (en) | 2002-09-12 |
| CZ20021355A3 (cs) | 2002-11-13 |
| NO20021850D0 (no) | 2002-04-19 |
| OA12081A (en) | 2006-05-04 |
| US6562792B1 (en) | 2003-05-13 |
| SK5472002A3 (en) | 2003-02-04 |
| HK1049672A1 (zh) | 2003-05-23 |
| HUP0203525A2 (hu) | 2003-02-28 |
| GT200000185A (es) | 2002-04-18 |
| JP2003512473A (ja) | 2003-04-02 |
| PE20010763A1 (es) | 2001-07-25 |
| EP1224197A1 (en) | 2002-07-24 |
| AU7549400A (en) | 2001-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25679A1 (es) | Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer | |
| BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
| YU30702A (sh) | Novi derivati benzoimidazola, korisni agensi protiv proliferacije | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
| GB9914486D0 (en) | Medicaments | |
| PA8472301A1 (es) | Derivados de isotiazol utiles como agentes anticancerosos | |
| CA2292359A1 (en) | Novel azalides and methods of making same | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| MXPA03005464A (es) | Agentes antivirales. | |
| BR0010938A (pt) | Derivados da 13-metil eritromicina | |
| EA199901016A1 (ru) | 9-оксим-производные эритромицина | |
| AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
| EP1109560A4 (en) | COMPOUNDS USEFUL AS AICARFT INHIBITORS | |
| AR023282A1 (es) | Derivados de higromicina | |
| HK1053109A1 (en) | Substituted homopiperidinyl benzimidazole compounds, pharmaceutical compositions comprising the same, methods for preparing them and the use for the preparation of a medicament of them | |
| BR0006299A (pt) | Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina | |
| AU6826700A (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| UY26421A1 (es) | Derivados de higromicina | |
| ECSP003744A (es) | Derivados de higromicina | |
| AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
| AR026285A1 (es) | Profarmacos de higromicina a | |
| ATE269704T1 (de) | Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens | |
| ECSP982529A (es) | Derivados de la 9-oxima eritromicina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |